Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.   BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

We’re delighted with the feedback that our over-labelling and MPW (Mawdsleys Pre Wholesale) teams received from Thea Pharmaceuticals when they delivered on a major project for a large chain of opticians, despite the goal posts shifting a few times.   Thea, a client of Mawdsleys 3PL division, MPW, needed Mawdsleys…